This study is the first study that provides useful guidelines to clinical microbiologists and technicians on the usefulness of full 16S rRNA sequencing, 59-end 527-bp 16S rRNA sequencing and the existing MicroSeq full and 500 16S rDNA bacterial identification system (MicroSeq, Perkin-Elmer Applied Biosystems Division, Foster City, California, USA) databases for the identification of all existing medically important anaerobic bacteria. Full and 527-bp 16S rRNA sequencing are able to identify 52-63% of 130 Gram-positive anaerobic rods, 72-73% of 86 Gram-negative anaerobic rods and 78% of 23 anaerobic cocci. The existing MicroSeq databases are able to identify only 19-25% of 130 Gram-positive anaerobic rods, 38% of 86 Gram-negative anaerobic rods and 39% of 23 anaerobic cocci. These represent only 45-46% of those that should be confidently identified by full and 527-bp 16S rRNA sequencing. To improve the usefulness of MicroSeq, bacterial species that should be confidently identified by full and/or 527-bp 16S rRNA sequencing but not included in the existing MicroSeq databases should be included.
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Comparison of bacterial gene sequences has shown that 16S rRNA gene sequencing can be used as a working standard for the classification and identification of bacteria. 1 The MicroSeq 500 16S rDNA bacterial identification system (MicroSeq, Perkin-Elmer Applied Biosystems Division, Foster City, California) has been designed for rapid and accurate identification of bacterial pathogens, using the 59-end 527-bp of the 16S rRNA gene. [2] [3] [4] [5] [6] [7] Recently, the company has also included a full 16S rRNA gene sequence (full-MicroSeq) database (http:// docs.appliedbiosystems.com/pebiodocs/00113462.pdf). Because identification of medically important anaerobic bacteria is notoriously difficult, 16S rRNA sequencing would be particularly useful for the identification of this group of bacteria. [8] [9] [10] [11] [12] Problems exist in both 16S rRNA sequencing and MicroSeq. When two different bacterial species share almost the same 16S rRNA sequence, this technique would not be useful for distinguishing them. Moreover, MicroSeq is further limited by the database of the system. 7 13 In this study, we systematically evaluated the potential usefulness of full and 527-bp 16S rRNA sequencing and the existing MicroSeq databases for identification of all known medically important anaerobic bacterial species.
MATERIALS AND METHODS
16S rRNA sequences of medically important anaerobic bacteria The medically important anaerobic bacterial species included in this study comprise all anaerobic bacterial species listed in the most recent edition of the Manual of clinical microbiology.
14 For each bacterial species, a list of the 16S rRNA sequence was retrieved from the GenBank database. In the list, the most representative 16S rRNA sequence for each species was chosen for analysis according to the following criteria: (1) strains with good phenotypic characterisation (eg, type strains); (2) strains isolated from humans; (3) sequences with fewer undetermined bases;and (4) longer sequences, especially those with better coverage of the 59 end.
Comparison of full 16S rRNA sequences of medically important anaerobic bacteria The percentage differences of the 16S rRNA sequences between the different species of medically important anaerobic bacteria were determined by pairwise alignment. 15 For sequences with undetermined bases, other 16S rRNA sequences of the same species were retrieved and the undetermined bases manually amended. If there was no other 16S rRNA sequence for the same species, the positions of the undetermined bases were deleted in the analysis.
Comparison of 527-bp 16S rRNA sequences of medically important anaerobic bacteria The 527-bp 16S rRNA sequence that should be amplified by the primers of MicroSeq were extracted from the full 16S rRNA sequence. The percentage differences of the resultant partial 16S rRNA sequences between the different species were determined by pairwise alignment. 15 
RESULTS

Supplementary
DISCUSSION
This study is the first to provide useful guidelines to clinical microbiologists and technicians on the usefulness of 16S rRNA sequencing for the identification of medically important anaerobic bacteria. Interpretation of 16S rRNA gene sequence results is often difficult for those with limited experience in the use of this technique for the identification of pathogenic bacteria. Owing to the large number of unvalidated 16S rRNA sequences in GenBank, inexperienced users often find it difficult to decide whether the ''first hit'' or ''closest match'' is the one that corresponds to the real identity of a bacterium. As for commercially available databases such as MicroSeq, their usefulness is largely limited by (a) the limited database and (b) the fact that the database also includes those bacterial species that obviously cannot be identified confidently by 16S rRNA sequencing, but no guideline is given on the limited usefulness of 16S rRNA sequencing for identification of such species. Therefore, we undertook this study, by using ''the most representative'' 16S rRNA sequences for each medically important anaerobic bacterium in GenBank, and analysing the usefulness of different forms of such a technique for the identification of medically important anaerobic bacteria.
Overall, both full and 527-bp 16S rRNA sequencing are very useful for the identification of medically important anaerobic bacteria to the genus level, but are only able to identify 62% and 68% of these bacteria confidently to the species level. In general, 16S rRNA sequencing is more useful for the identification of medically for important anaerobic Gramnegative rods and cocci than for Gram-positive rods (table 1) . However, it is not particularly useful for speciation of Fusobacterium species, with only 1 of 11 medically important Fusobacterium species being identified confidently to the species level. This is of major clinical relevance because F necrophorum, a virulent bacterium that causes peritonsillar abscess, is associated with serious complications, including jugular vein septic thrombophlebitis (Lemierre syndrome), lung abscess and empyema. Of note is that the 16S rRNA sequences is not able to confidently speciate Clostridium botulinum, C septicum, C tertium and C tetani, which are associated with important clinical syndromes.
The existing MicroSeq databases need to be markedly expanded. Overall, the existing MicroSeq databases are able to confidently identify only 19-25% Gram-positive anaerobic rods, 38% Gram-negative anaerobic rods and 39% anaerobic cocci (table 1) . These represent only 45-46% of those that should be confidently identified by full and 527-bp rRNA sequencing. When compared with the manual interpretation of 16S rRNA sequencing results, the MicroSeq databases are particularly not good for some major genera, such as Actinomyces, Bifidobacterium, Eubacterium, Porphyromonas and Prevotella (table 1) . To improve the usefulness of the MicroSeq databases, bacterial species that should be confidently identified by 16S rRNA sequencing but are not included in the existing MicroSeq databases should be included (table 2). Take-home messages N Full and 59-end 527-bp 16S rRNA sequencing are able to identify 52-63%, 72-73% and 78% of medically important Gram-positive anaerobic rods, Gram-negative anaerobic rods and anaerobic cocci, respectively.
N The existing MicroSeq databases are able to identify only 19-25%, 38% and 39% of medically important Grampositive anaerobic rods, Gram-negative anaerobic rods and anaerobic cocci, respectively, representing only 45-46% of those that should be confidently identified by full and 59-end 527-bp 16S rRNA sequencing.
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